The Modified Arch Landing Areas Nomenclature identifies hostile zones for endograft deployment: a confirmatory biomechanical study in patients treated by thoracic endovascular aortic repair†.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 06 08 2018
revised: 22 10 2018
accepted: 23 10 2018
pubmed: 12 12 2018
medline: 3 10 2020
entrez: 12 12 2018
Statut: ppublish

Résumé

Our goal was to confirm whether the Modified Arch Landing Areas Nomenclature (MALAN) for thoracic endovascular aortic repair, in which each landing area is described by indicating both the proximal landing zone (PLZ) and the type of arch (e.g. 0/I), identifies unfavourable landing zones for endograft deployment in diseased aortas. Preoperative computed tomography angiography scans of 10 patients scheduled for thoracic endovascular aortic repair for aneurysm or penetrating ulcer of the arch and with a potential hostile PLZ were reviewed. Five had proximal deployment planned in MALAN area 3/III and 5, in MALAN area 2/III. The angulation of each PLZ was calculated. Computational fluid dynamics modelling was used to compute magnitude and orientation of pulsatile displacement forces in each PLZ. Normalized values based on PLZ areas (i.e. equivalent surface traction) were calculated. Results were compared to those obtained in healthy controls stratified by the MALAN. Angulation was severe (>60°) in MALAN areas 3/III and 2/III, which was consistent with the findings obtained in healthy controls. Increased magnitude (P = 0.021) and unfavourable orientation (i.e. orthogonal to the longitudinal aortic axis) of equivalent surface traction (P = 0.011) was also found in these areas compared to the adjacent ones, following the same pattern seen in the controls. Adverse events related to proximal endograft performance were reported in 3/10 cases. This study confirms in diseased aortas initial proof-of-concept findings on the predictive value of the MALAN to identify landing areas with a geometric and haemodynamic environment hostile for thoracic endovascular aortic repair. These adverse biomechanical features may entail an increased risk of dismal endograft performance.

Identifiants

pubmed: 30535119
pii: 5232671
doi: 10.1093/ejcts/ezy409
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

990-997

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Massimiliano M Marrocco-Trischitta (MM)

Division of Vascular Surgery II, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.
Thoracic Aortic Research Center, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.

Rodrigo M Romarowski (RM)

3D and Computer Simulation Laboratory, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.

Hector W de Beaufort (HW)

Thoracic Aortic Research Center, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.

Michele Conti (M)

Department of Civil Engineering and Architecture, Beta-Lab, University of Pavia, Pavia, Italy.

Renato Vitale (R)

Division of Vascular Surgery II, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.

Francesco Secchi (F)

Division of Radiology, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.

Ferdinando Auricchio (F)

Department of Civil Engineering and Architecture, Beta-Lab, University of Pavia, Pavia, Italy.

Santi Trimarchi (S)

Division of Vascular Surgery II, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.
Thoracic Aortic Research Center, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.
Department of "Scienze Biomediche per la Salute", University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH